Clinomic secures 23 million euros in Series B financing round

Cologne/Aachen — MedTech startup Clino­mic, a pioneer in digi­tal inten­sive care medi­cine, announ­ces the successful comple­tion of a Series B finan­cing round of 23 million euros. The round was co-led by the DeepT­ech & Climate Fund (DTCF) and a private family office. The funds will be used to expand the company’s presence in inter­na­tio­nal markets and further deve­lop its AI-powered health­care solutions. 

A HEUKING team led by Colo­gne part­ner Dr. Oliver Bött­cher and Sala­ried Part­ner Mark Ross­broich provi­ded legal advice to the med-tech start-up Clino­mic GmbH on this finan­cing round.

Foun­ded in 2019 by inten­sive care physi­ci­ans at RWTH Aachen Univer­sity, Clinomic’s goal with Mona, an AI-supported plat­form for inten­sive care units, is to improve medi­cal decis­i­ons, opti­mize work­flows and signi­fi­cantly increase the quality of care through struc­tu­red, real-time data. Mona inte­gra­tes medi­cal hard­ware, soft­ware and data analy­sis in a single system and is desi­gned to trans­form inten­sive care so that it meets both human and tech­ni­cal stan­dards for pati­ents and medi­cal staff. 

Georg Grie­se­mann, CEO of Clino­mic, comm­ents: “We are proud to be able to further advance our vision of better inten­sive care medi­cine with such strong part­ners. This funding will enable us to expand our inter­na­tio­nal acti­vi­ties in a targe­ted manner, deepen our AI exper­tise and scale data-driven solutions.”

Günther Bogen­rie­der (photo), Invest­ment Mana­ger at DTCF, adds: “From our first discus­sions, it became clear how Clino­mic is solving key chal­lenges in health­care with the help of AI — and doing so with a tangi­ble, measura­ble impact. Georg, Arne, Lukas and their outstan­ding team are rede­fi­ning inten­sive care medicine. 

Clino­mic GmbH, a medi­cal tech­no­logy start-up from Aachen, was foun­ded in 2019 as a spin-off of RWTH Aachen Univer­sity and deve­lops intel­li­gent assis­tance systems for inten­sive care units. Its main product, “Mona”, uses arti­fi­cial intel­li­gence and speech proces­sing to analyze medi­cal data and support nursing staff. The inter­di­sci­pli­nary team curr­ently consists of over 70 experts. 

Consul­tant Clino­mic GmbH: HEUKING

Dr. Oliver Bött­cher, Mark Ross­broich, LL. M. (King’s College London) (both lead, both venture capi­tal), Dr. Ruben A. Hofmann (IP, media & tech­no­logy), all Cologne;
Dr. Frede­rik Wiemer (anti­trust law), Hamburg;
Michael Kömpel, Meike Dani­els, Stefan Cesar (venture capi­tal), all Cologne 

About Clino­mic

Clino­mic is a medi­cal tech­no­logy start-up foun­ded by inten­sive care physi­ci­ans from RWTH Aachen Univer­sity Hospi­tal. With its central solu­tion Mona, the company combi­nes state-of-the-art AI tech­no­logy with advan­ced data analy­sis to opti­mize work­flows in inten­sive care units, reduce the admi­nis­tra­tive burden and sustain­ably improve pati­ent outco­mes. By inte­gra­ting hard­ware, soft­ware and data services on a single plat­form, Clino­mic is setting new global stan­dards in digi­tal inten­sive care medi­cine and driving the moder­niza­tion of acute care world­wide. www.clinomic.ai

About the DeepT­ech & Climate Fund

The DeepT­ech & Climate Fund (DTCF) finan­ces high-growth DeepT­ech and Clima­te­Tech compa­nies in Germany and Europe with up to EUR 30 million per invest­ment. As an anchor inves­tor and part­ner of long-term orien­ted Euro­pean inves­tors, the DTCF offers support to compa­nies with long deve­lo­p­ment cycles and high finan­cing requi­re­ments in order to imple­ment a sustainable growth stra­tegy and actively contri­bu­tes to the expan­sion of the tech­no­logy ecosys­tem. The fund acts as a bridge between inves­tors, SMEs and inno­va­tive start-ups in the fields of climate, compu­ting, indus­try and life scien­ces. Finan­ced by the Future Fund and the ERP Special Fund, the DTCF plans to invest 1 billion euros in the coming years to streng­then the Euro­pean tech­no­logy ecosys­tem. www.dtcf.de